Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SCB 1019

Drug Profile

SCB 1019

Alternative Names: RSV F antigen vaccine; SCB-1019; SCB-1019T

Latest Information Update: 19 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Clover Biopharmaceuticals
  • Class Respiratory syncytial virus vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Respiratory syncytial virus infections

Most Recent Events

  • 07 May 2025 Clover Biopharmaceuticals completes a phase I trial in Respiratory syncytial virus infections (In volunteers, In adults, In the elderly) in Australia (Parenteral) (NCT06194318)
  • 24 Mar 2025 Clover Biopharmaceuticals completes enrolment of patients in phase I trial in Respiratory syncytial virus infections (In children) in Australia (NCT06666179)
  • 23 Mar 2025 US FDA completes IND application for phase I trial in Respiratory syncytial virus infections

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top